Literature DB >> 26204206

Glucagonoma Pancreatic Neuroendocrine Tumor Treated With 177Lu DOTATATE Induction and Maintenance Peptide Receptor Radionuclide Therapy.

William Makis1, Karey McCann, Terence A Riauka, Alexander J B McEwan.   

Abstract

A 56-year-old man presented with a history of 2 prior resections of a recurrent pancreatic glucagonoma in the past 4 years. Workup revealed new liver and abdominal nodal metastases with a rising serum glucagon level. He was started on peptide receptor radionuclide therapy with Lu DOTATATE, and his disease stabilized, while his glucagon levels decreased and also stabilized. After 4 induction and 2 maintenance cycles, he remains progression free for 23 months.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26204206     DOI: 10.1097/RLU.0000000000000891

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  6 in total

Review 1.  Treatment of symptomatic neuroendocrine tumor syndromes: recent advances and controversies.

Authors:  Tetsuhide Ito; Lingaku Lee; Robert T Jensen
Journal:  Expert Opin Pharmacother       Date:  2016-09-23       Impact factor: 3.889

Review 2.  Management of functional neuroendocrine tumors of the pancreas.

Authors:  Kjell Öberg
Journal:  Gland Surg       Date:  2018-02

3.  Proof of concept for stereotactic body radiation therapy in the treatment of functional neuroendocrine neoplasms.

Authors:  Sten Myrehaug; Julie Hallet; William Chu; Elaine Yong; Calvin Law; Angela Assal; Olexandra Koshkina; Alexander V Louie; Simron Singh
Journal:  J Radiosurg SBRT       Date:  2020

4.  Spleen-preserving distal pancreatectomy and lymphadenectomy for glucagonoma syndrome: A case report.

Authors:  Xuefeng Cao; Xixiu Wang; Yanmin Lu; Baolei Zhao; Jian Shi; Qinghai Guan; Xingyuan Zhang
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

5.  Malignant transformation of glucagonoma with SPECT/CT In-111 OctreoScan features: A case report.

Authors:  Giuseppe Corrias; Natally Horvat; Serena Monti; Olca Basturk; Oscar Lin; Luca Saba; Lisa Bodei; Diane L Reidy; Lorenzo Mannelli
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

6.  Peptide receptor radionuclide therapy controls inappropriate calcitriol secretion in a pancreatic neuro-endocrine tumor: a case report.

Authors:  Maarten Haemels; Thierry Delaunoit; Koen Van Laere; Eric Van Cutsem; Chris Verslype; Christophe M Deroose
Journal:  BMC Gastroenterol       Date:  2020-10-02       Impact factor: 3.067

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.